Nadelmann, Jennifer B.
Miller, Charles G.
McGeehan, Brendan
Yu, Yinxi
VanderBeek, Brian L. http://orcid.org/0000-0003-4953-118X
Funding for this research was provided by:
University of Pennsylvania Core Grant for Vision Research (2P30EY001583)
Research to Prevent Blindness
Paul MacKall and Evanina Bell MacKall Trust
Article History
Received: 12 April 2023
Revised: 11 September 2023
Accepted: 7 October 2023
First Online: 17 October 2023
Declarations
:
: All handling of the data used in this study involving human participants was in accordance with the ethical standards of the University of Pennsylvania and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was deemed exempt from review by the Institutional Review Board at the University of Pennsylvania due to the de-identified nature of the data.
: The need for informed consent was waived due to the de-identified nature of the data.
: Brian VanderBeek previously consulted for EyePoint Pharmaceuticals. Charles Miller is an employee of Regeneron Pharmaceuticals. No other financial relationships or potential conflicts exist for any author.